film coated tablets containing no markings. clinical trials

A Randomized, Double-Blind (Sponsor-Unblinded), Placebo-Controlled, Adaptive Study to Investigate the Antiviral Effect, Safety, Tolerability and Pharmacokinetics of VH3739937 in Treatment-Naïve Adults Living with HIV-1

This study is testing a new medicine, VH3739937, for people recently diagnosed with HIV. We want to see how well it lowers the amount of virus in the blood and if it's safe to use. Some participants will receive a dummy pill (placebo) instead of the actual medicine.